Healthcare Aug 11, 2020 11:04 AM (GMT+8) · EqualOcean
Wallaby Medial, a Shanghai-based startup focusing on neuro-interventional devices, announced the close of Series B+ of multi-hundreds Chinese yuan. The financing will support the company’s research on apoplexy treatments and expand the Western world market, Japan and South America. Its differentiated embolic coil system, the Avenir® Coil System, is recognized by CE Mark (European Union), FDA (the US) and PMDA (Japan).